Work

Emerging Therapeutic Strategies for Fragile X Syndrome: Q&A

Year: 2022

Type: editorial

Abstract: Understanding how best to treat aspects of Fragile X syndrome has the potential to improve the quality of life of affected individuals. Such an effective therapy has, as yet, remained elusive. In this article, we ask those researching or affected by Fragile X syndrome their views on the current state of research and from where they feel the most likely therapy may emerge.

Source: ACS Chemical Neuroscience

DOI: 10.1021/acschemneuro.2c00674

Authors: Ghassan Alusi, Elizabeth Berry-Kravis, David Nelson, Lauren L. Orefice, Sam A. Booker

Institutions: Barts Health NHS Trust, Rush University Medical Center, Baylor College of Medicine, Harvard University, Massachusetts General Hospital, Simons Initiative for the Developing Brain, University of Edinburgh

Language: English

Topic: Genetics and Neurodevelopmental Disorders

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $5,000

OpenAlex ID: W4312196494

Cites: 9

Cited by: 4

Related to: 10